Celanese
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Celanese's revenues will wane -1.9% and EPS will wane -14.5%.
The average estimate for revenue is $1.72 billion. On the bottom line, the average EPS estimate is $1.42.
Revenue details
Last quarter, Celanese chalked up revenue of $1.63 billion. GAAP reported sales were 2.8% higher than the prior-year quarter's $1.59 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, non-GAAP EPS came in at $0.72. GAAP EPS of $1.15 for Q1 were 28% higher than the prior-year quarter's $0.90 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 16.5%, 560 basis points worse than the prior-year quarter. Operating margin was 5.9%, 570 basis points worse than the prior-year quarter. Net margin was 11.2%, 230 basis points better than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $6.87 billion. The average EPS estimate is $4.32.
Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 355 members out of 385 rating the stock outperform, and 30 members rating it underperform. Among 92 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 88 give Celanese a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Celanese is outperform, with an average price target of $57.18.
- Add Celanese to My Watchlist.